Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Cash from Investing Activities (2021 - 2025)

Senti Biosciences has reported Cash from Investing Activities over the past 5 years, most recently at -$184000.0 for Q2 2025.

  • For Q2 2025, Cash from Investing Activities changed N/A year-over-year to -$184000.0; the TTM value through Dec 2025 reached -$184000.0, down 641.18%, while the annual FY2025 figure was -$184000.0, 641.18% down from the prior year.
  • Cash from Investing Activities for Q2 2025 was -$184000.0 at Senti Biosciences, down from -$11000.0 in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $21.1 million in Q3 2023 and troughed at -$230.0 million in Q2 2021.
  • A 5-year average of -$49.5 million and a median of -$7.4 million in 2022 define the central range for Cash from Investing Activities.
  • Biggest five-year swings in Cash from Investing Activities: skyrocketed 262.8% in 2023 and later plummeted 110.89% in 2024.
  • Year by year, Cash from Investing Activities stood at -$230.0 million in 2021, then soared by 78.64% to -$49.1 million in 2022, then skyrocketed by 100.21% to $101000.0 in 2023, then plummeted by 110.89% to -$11000.0 in 2024, then tumbled by 1572.73% to -$184000.0 in 2025.
  • Business Quant data shows Cash from Investing Activities for SNTI at -$184000.0 in Q2 2025, -$11000.0 in Q4 2024, and $60000.0 in Q3 2024.